Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-26

Clinical Trial Update: Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction [Phase 2]

View source ↗

Summary

This clinical trial update summarizes the results of a Phase 2 study evaluating whether atazanavir can improve endothelial dysfunction in individuals with type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATAZANAVIR (atazanavir)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Type 2 Diabetes Mellitus Related Endothelial Dysfunction | Phase 2 | Status: COMPLETED